ALWAGHT- An Iranian court ordered the US government and officials to pay $12.615 billion in compensation for the physical and mental harm caused to Iranian thalassemia patients due to sanctions.
An Iranian court has ruled that the US government and 17 American individuals and entities must pay $12.615 billion in compensation for the harm caused to Iranian thalassemia patients due to sanctions. The lawsuit, filed by 438 Iranian plaintiffs, argued that US sanctions disrupted access to essential medications, worsening patients' conditions and increasing their medical costs.
The court found that US sanctions forced patients to rely on low-quality drugs, exacerbating their symptoms and leading to significant physical and mental suffering. The ruling also noted that the emotional distress caused by the sanctions limited patients' social interactions and deprived them of equal opportunities in life.
Thalassemia is a chronic blood disorder that requires lifelong treatment with blood transfusions and medication. According to Iran’s Health Ministry, approximately 18,800 Iranians have the condition, with 15,500 suffering from the severe form, thalassemia major, which necessitates continuous medical care.
